Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems
Published March 11, 2020 · Recall initiated: August 15, 2019
Summary
FDA records medical device Class II recall Z-1430-2020, published March 11, 2020 and initiated August 15, 2019. Recalling firm: Normand-Info S.A.S.U.; Status: Terminated; Reported quantity: 6479; Lot: All serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Normand-Info S.A.S.U.
- Distributor
- U.S.: NY, AZ, FL, NJ, MA, OH, CA, IL, NC, OK, IN, KY, OR, MI, WI, PA, UT, GA, VA, TX, NE, SD, IA, MN, MD, DE, SC, MT, WV, LA, MO, TN, NM, NV, HI, WA, WY, AL, AR, MS, RI, ID, ME, DC, ND, AK, CO, CT, KS, NH, VT
- Lot
- All serial numbers
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- France
Related recalls
- FDARemisol Advance running Software Version 1.12 The Normand Info Remisol Advance Data Manager collects andAugust 12, 2020
- FDATriglycerides Reagent (TG 2 x 300), REF: 445850, For In Vitro Diagnostic Use, Rx Only, UDI: 15099590233228March 11, 2020
- FDABard Biopsy EnCor Probe, MRI, 10G Trocar Tip, REF number ECPMR0110G, packaged individually in sterile pouches,March 11, 2020
- FDAEnzymatic Creatinine Reagent (CR-E 2 X 200), REF A60298, For in Vitro Diagnostic Use, Rx Only, UDI:March 11, 2020
- FDAAtellica IM Humidity Pack (Qty 5), SMN 11313505, UDI 00630414234526, Software Version V1.21.0 and lower -March 11, 2020
- FDADeRoyal Sterile Custom Kits containing Cardinal Health Gowns. Sold as the following: ASC Thyroid PackMarch 11, 2020
Questions about this recall
Was Remisol Advance running on hardware with Windows XP, Windows 7, Windows Server 2003 and Windows Server 2008 operating systems recalled?
Yes. FDA published recall Z-1430-2020 on March 11, 2020. Reported hazard: A patch was released for a critical remote code execution vulnerability in remote desktop services. This vulnerability can be exploited remotely without authentication on certain operating systems. An attacker who successfully exploited this vulnerability could execute arbitrary code on the target system; then install programs; view, change, or delete data; or create new accounts with full user rights. If the vulnerability could be exploited locally, it would lock down the computer.
What should I do if I have this product?
Voluntary: Firm initiated · Letter